{"transactions":[{"id":3447392,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-06T00:11:39.000Z","date":"2019-08-03","kind":"sale","acquired":false,"shares":1328,"price":16.7,"value":22177.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 1,328 shares represents the shares that were sold by the reporting person to cover minimum statutory obligations due upon vesting of 3,750 restricted stock award shares."}],"balance_after":38584,"source":{"system":"sec-edgar","filing":"0001179110-19-009165","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019009165/edgar.xml","form_type":"4"}},{"id":3504972,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-06-03T21:22:59.000Z","date":"2019-06-01","kind":"exercise","acquired":false,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":4084,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2043},"source":{"system":"sec-edgar","filing":"0001179110-19-007033","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/edgar.xml","form_type":"4"}},{"id":3504971,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T21:22:59.000Z","date":"2019-06-01","kind":"tax_withholding","acquired":false,"shares":706,"price":14.75,"value":10413.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 706 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":39912,"source":{"system":"sec-edgar","filing":"0001179110-19-007033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/edgar.xml","form_type":"4"}},{"id":3504970,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T21:22:59.000Z","date":"2019-06-01","kind":"exercise","acquired":true,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40618,"source":{"system":"sec-edgar","filing":"0001179110-19-007033","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/edgar.xml","form_type":"4"}},{"id":3639055,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-23T00:04:37.000Z","date":"2019-02-22","kind":"exercise","acquired":false,"shares":3884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":7767,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3884},"source":{"system":"sec-edgar","filing":"0001179110-19-002465","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/edgar.xml","form_type":"4"}},{"id":3639054,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-23T00:04:37.000Z","date":"2019-02-22","kind":"tax_withholding","acquired":false,"shares":1343,"price":16.81,"value":22575.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 1,343 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":38575,"source":{"system":"sec-edgar","filing":"0001179110-19-002465","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/edgar.xml","form_type":"4"}},{"id":3639053,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-23T00:04:37.000Z","date":"2019-02-22","kind":"exercise","acquired":true,"shares":3884,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39918,"source":{"system":"sec-edgar","filing":"0001179110-19-002465","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/edgar.xml","form_type":"4"}},{"id":3646431,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-21T01:10:35.000Z","date":"2019-02-03","kind":"sale","acquired":false,"shares":2536,"price":16.41,"value":41615.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares.  This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares.  This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares.  This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares.  This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment."}],"balance_after":31566,"source":{"system":"sec-edgar","filing":"0001179110-19-002193","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002193/edgar.xml","form_type":"4/A","original_submission_date":"2019-02-05"}},{"id":3653986,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-15T22:36:01.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":6790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":20370,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6790},"source":{"system":"sec-edgar","filing":"0001179110-19-002007","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/edgar.xml","form_type":"4"}},{"id":3653985,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-15T22:36:01.000Z","date":"2019-02-14","kind":"tax_withholding","acquired":false,"shares":2322,"price":16.54,"value":38405.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 2,322 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":36067,"source":{"system":"sec-edgar","filing":"0001179110-19-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/edgar.xml","form_type":"4"}},{"id":3653984,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-15T22:36:01.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":6790,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38389,"source":{"system":"sec-edgar","filing":"0001179110-19-002007","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/edgar.xml","form_type":"4"}},{"id":3657052,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-14T23:28:15.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":37538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter."}],"balance_after":37538,"derivative":{"exercise_price":0,"exercise_date":"2020-02-12","underlying":"Common Stock","underlying_shares":37538},"source":{"system":"sec-edgar","filing":"0001179110-19-001934","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019001934/edgar.xml","form_type":"4"}},{"id":3657051,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-02-14T23:28:15.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":71602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests one-fourth on such date and then 1/48th monthly thereafter."}],"balance_after":71602,"derivative":{"exercise_price":16.65,"exercise_date":"2020-02-12","expiration_date":"2029-02-12","underlying":"Common Stock","underlying_shares":71602},"source":{"system":"sec-edgar","filing":"0001179110-19-001934","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019001934/edgar.xml","form_type":"4"}},{"id":3674793,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-05T21:12:46.000Z","date":"2019-02-03","kind":"tax_withholding","acquired":false,"shares":2503,"price":16.12,"value":40348.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 2,503 shares represents the shares that were withheld by the issuer as payment for minimum statutory obligations due upon vesting of 6,165 restricted stock award shares."}],"balance_after":31599,"source":{"system":"sec-edgar","filing":"0001179110-19-001321","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019001321/edgar.xml","form_type":"4"}},{"id":3852010,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-06T22:58:39.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":1305,"price":17.08,"value":22289.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 1,305 shares represents the shares that were withheld by the issuer as payment for minimum statutory obligations due upon vesting of 3,750 restricted stock award shares."}],"balance_after":34102,"source":{"system":"sec-edgar","filing":"0001179110-18-010332","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018010332/edgar.xml","form_type":"4"}},{"id":3905808,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-06-05T20:06:18.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer."}],"balance_after":6127,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2043},"source":{"system":"sec-edgar","filing":"0001179110-18-008049","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018008049/edgar.xml","form_type":"4"}},{"id":3905807,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-05T20:06:18.000Z","date":"2018-06-01","kind":"tax_withholding","acquired":false,"shares":712,"price":18.59,"value":13236.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported disposition of 712 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations."}],"balance_after":35407,"source":{"system":"sec-edgar","filing":"0001179110-18-008049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018008049/edgar.xml","form_type":"4"}},{"id":3905806,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":155670,"kind":"person","name":"Chondros Dimitrios","position":1,"cik":"0001739693","reported_name":"Chondros Dimitrios","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-05T20:06:18.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36119,"source":{"system":"sec-edgar","filing":"0001179110-18-008049","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018008049/edgar.xml","form_type":"4"}}]}